enVVeno Medical (NVNO) Capital Expenditures (2017 - 2024)

enVVeno Medical's Capital Expenditures history runs 8 years deep, the most recent figure standing at $4000.0 for Q4 2024.

• On a quarterly basis, Capital Expenditures changed 0.0% year-over-year to $4000.0 in Q4 2024; TTM through Dec 2025 was $13000.0, a 64.86% decrease from a year earlier, with the FY2025 full-year figure at $5000.0, down 86.49% from the prior year.
• Capital Expenditures eased to $4000.0 in Q4 2024 per NVNO's latest filing, from $9000.0 in the prior quarter.
• Across five years, Capital Expenditures topped out at $152000.0 in Q3 2021 and bottomed at $3000.0 in Q3 2023.
• The 5-year median for Capital Expenditures is $17500.0 (2022), against an average of $36664.6.
• Across the five-year window, Capital Expenditures surged 508.85% in 2021 and slumped 92.75% in 2023, its largest moves.
• Year by year, Capital Expenditures stood at $27540.0 in 2020, then surged by 136.02% to $65000.0 in 2021, then slumped by 86.15% to $9000.0 in 2022, then sank by 55.56% to $4000.0 in 2023, then changed by 0.0% to $4000.0 in 2024.
• Per Business Quant, the three latest NVNO Capital Expenditures figures stand at $4000.0 (Q4 2024), $9000.0 (Q3 2024), and $14000.0 (Q2 2024).